You are here: Industry Insights > Ono Pharmaceutical

News List

Neurimmune and Ono Pharmaceutical extend drug discovery partnership pharmaceutical-business-review
January 18, 2022
Neurimmune and Ono Pharmaceutical have announced the expansion of a drug discovery partnership agreement to develop antibody drugs for neurodegenerative diseases.
SK Biopharmaceuticals, Ono Pharmaceutical Enter Licensing Agreement for Cenobamate in Japan prnasia
October 15, 2020
SK Biopharmaceuticals and Ono Pharmaceutical announced that they have entered into an exclusive licensing agreement for Ono to develop and commercialize cenobamate in Japan.
Bayer, Bristol-Myers Squibb, Ono Pharmaceutical to Investigate Stivarga, Opdivo Combo Therapy americanpharmaceuticalreview
July 19, 2019
Bayer, Bristol-Myers Squibb, and Ono Pharmaceutical announced the three companies have entered into a clinical collaboration agreement to evaluate the combination of Bayer's kinase inhibitor Stivarga® (regorafenib) and ...
Cancer immunotherapy alliance formed by CR UK, Lifearc and Ono Pharma Form pharmatimes
March 28, 2019
Cancer Research UK, LifeArc and Ono Pharmaceutical Co have collaborated to form a multi-million-pound drug discovery alliance.
Ono files for approval of ONO-7643 in Japan biospectrumasia
November 29, 2018
Ono Pharmaceutical announced today that ONO has submitted in Japan an application for manufacturing and marketing approval of anamorelin hydrochloride (ONO-7643) (“Anamorelin”)...
Ono Pharma submits marketing approval of metyrosine in Japan biospectrumasia
May 03, 2018
This application is based on a multicenter, open-label, non-comparative study and its accompanying continuous administration study